Monomeric B27 Lys Destripeptide Insulin: Semisynthesis, Characterization and Biological Activity
DING Jin-Guo, CUI Da-Fu, ZHANG You-Shang*
( Institute of
Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences,
the Chinese Academy of Sciences, Shanghai 200031, China )
Abstract
In this paper, we report the semisynthesis of B27 Lys destripeptide insulin
(B27 Lys DTrI), i.e. destetrapeptide insulin with an additional Lys residue
at the C-terminus of B-chain. B27 Lys DTrI is also monomeric as shown by gel
filtration. Its in vivo biological activity is 80% in comparison with
that of native insulin. The addition of a Lys residue at the C-terminus of
B-chain makes it possible to obtain monomeric B27 Lys DTrI from a precursor
expressed in Saccharomyces cerevesiae by tryptic hydrolysis instead of the
less efficient tryptic transpeptidation.
Key
words B27 Lys destripeptide insulin; biological activity;
monomeric insulin
Corresponding
author: Tel,
86-21-54921237; Fax, 86-21-54921011; e-mail,
[email protected]
